Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives

被引:0
|
作者
A. Taylor Kelley
Jordynn Wilcox
Jacob D. Baylis
Norah L. Crossnohere
John Magel
Audrey L. Jones
Adam J. Gordon
John F. P. Bridges
机构
[1] Informatics,Division of General Internal Medicine, Department of Internal Medicine
[2] Decision-Enhancement and Analytic Sciences (IDEAS) Center,Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine
[3] VA Salt Lake City Health Care System,Office of the Director
[4] Vulnerable Veteran Innovative Patient-aligned Care Team (VIP),Division of General Internal Medicine, Department of Internal Medicine
[5] VA Salt Lake City Health Care System,Department of Physical Therapy and Athletic Training
[6] University of Utah School of Medicine,Division of Epidemiology, Department of Internal Medicine
[7] University of Utah School of Medicine,Greater Intermountain Node (GIN) of the NIDA Clinical Trials Network, Division of Epidemiology, Department of Internal Medicine
[8] VA Salt Lake City Health Care System,Department of Biomedical Informatics
[9] The Ohio State University College of Medicine,undefined
[10] University of Utah College of Health,undefined
[11] University of Utah School of Medicine,undefined
[12] University of Utah School of Medicine,undefined
[13] The Ohio State University College of Medicine,undefined
来源
关键词
Opioid use disorder; Medication treatment for opioid use disorder; Access to care; Provider incentives; Primary care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2147 / 2155
页数:8
相关论文
共 50 条
  • [41] Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder
    Gardner-Buckshaw, Stacey L.
    Perzynski, Adam T.
    Spieth, Russell
    Khaira, Poojajeet
    Delos Reyes, Chris
    Novak, Laura
    Kropp, Denise
    Caron, Aleece
    Boltri, John M.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (02) : 251 - 266
  • [42] Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
    Hagan, Scott
    Achtmeyer, Carol E.
    Hood, Carly
    Hawkins, Eric J.
    Williams, Emily C.
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [43] Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
    Solmeyer, Anna R.
    Berger, Aaron T.
    Barton, Sean L.
    Nguyen, Benjamin
    Bart, Gavin B.
    Grahan, Brian
    Bell, Heather J.
    DeVine, Kurt M.
    Merrick, Weston
    [J]. JAMA HEALTH FORUM, 2022, 3 (11): : E224149
  • [44] Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report
    Scott Hagan
    Carol E. Achtmeyer
    Carly Hood
    Eric J. Hawkins
    Emily C. Williams
    [J]. Addiction Science & Clinical Practice, 16
  • [45] Increasing access to medications for opioid use disorder: Policy analysis and proposals
    Latronica, James R.
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2021, 39 (03) : 421 - 424
  • [46] MICRODOSE BUPRENORPHINE INDUCTION: EXPANDING TREATMENT ACCESS TO HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER
    Button, Dana
    Hartley, Jennifer
    Robbins, Jonathan
    Levander, Ximena A.
    Englander, Honora
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S122 - S122
  • [47] The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
    Joao P. De Aquino
    Suprit Parida
    Mehmet Sofuoglu
    [J]. Clinical Drug Investigation, 2021, 41 : 425 - 436
  • [48] The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
    De Aquino, Joao P.
    Parida, Suprit
    Sofuoglu, Mehmet
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 425 - 436
  • [49] Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
    Berkeley Franz
    Lindsay Y. Dhanani
    O. Trent Hall
    Daniel L. Brook
    Cheyenne Fenstemaker
    Janet E. Simon
    William C. Miller
    [J]. Addiction Science & Clinical Practice, 19
  • [50] Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
    Franz, Berkeley
    Dhanani, Lindsay Y.
    Hall, O. Trent
    Brook, Daniel L.
    Fenstemaker, Cheyenne
    Simon, Janet E.
    Miller, William C.
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2024, 19 (01)